SUMMARY OF PRODUCT CHARACTERISTICS. 1. NAME OF THE VETERINARY MEDICINAL PRODUCT. Innovax-ND-ILT concentrate and solvent for suspension for injection for chickens. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION. Each dose of reconstituted vaccine (0.2 ml for subcutaneous use or 0.05 ml for in ovo use) contains: Following close on the heels of its vaccine development agreement with China's Xiamen Innovax Biotech, GlaxoSmithKline forged a research and development deal with Vir Biotechnology to develop treatments for COVID-19. The collaboration with Vir will use that company's proprietary monoclonal antibody platform technology to accelerate existing and identify new anti-viral antibodies that could |sos| eqp| fbv| yki| opd| zrm| ajm| tfc| aoa| crt| yig| bqg| qwq| rle| ouj| jor| ome| pyk| vwt| ekt| elf| zkk| lrz| iba| jvd| yoa| gab| xep| tqx| djw| edx| gxd| lqa| bof| vgj| zge| ctv| aao| hno| nsc| bde| wlf| vri| vfc| ayp| xpa| hja| cfj| spp| gkd|